Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 13/20 | 0.57 |
| ▸ | F11 | P03951 | 6/20 | 0.57 |
| ▸ | TPSB2 | P20231 | 5/20 | 0.57 |
| ▸ | PLAU | P00749 | 2/20 | 0.57 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.57 |
| ▸ | PLG | P00747 | 1/20 | 0.57 |
| ▸ | F7 | P08709 | 1/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23219040 | 1.00 | CFD (0.57) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL29591472 | 0.93 | CFD (0.57) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL23218506 | 0.93 | CFD (0.57) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL23218034 | 0.93 | CFD (0.58) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL29852919 | 0.93 | CFD (0.58) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL23218477 | 0.91 | CFD (0.70) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL29592336 | 0.91 | CFD (0.70) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL29591292 | 0.90 | CFD (0.55) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL23218862 | 0.90 | CFD (0.55) | CFDF11TPSB2PLAUKLKB1 | |
| SCHEMBL23218261 | 0.89 | CFD (0.54) | CFDF11TPSB2PLAUKLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4041238-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | Biocryst Pharmaceuticals, Inc. (US) | 2022-08-17 | — | — | EP | disclosed |
| CN-114502168-A | Oral complement factor D inhibitors | 拜奥克里斯特制药公司 | 2022-05-13 | — | — | CN | disclosed |